Large-scale testing (Phase 3)Study completedNCT00558298
What this trial is testing
A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.
Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen, LP 811